Moleculin Biotech, Inc.(MBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MBRX Moleculin Biotech, Inc.

休市中 09-11 16:00:00 EDT

0.7150

-0.1149

-13.85%

盘后0.7400

+0.0250+3.50%

19:58 EDT

最高0.8990	最低0.7100	成交量193.07万
今开0.8500	昨收0.8299	日振幅22.77%
总市值1,393万	流通市值1,218万	总股本1,948万
成交额151.70万	换手率11.34%	流通股本1,703万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MBRX","market":"US","secType":"STK","nameCN":"Moleculin Biotech, Inc.","latestPrice":0.715,"timestamp":1789156800000,"preClose":0.8299,"halted":0,"volume":1930723,"hourTrading":{"tag":"盘后","latestPrice":0.74,"preClose":0.715,"latestTime":"19:58 EDT","volume":9957,"amount":7416.9932,"timestamp":1789171129930,"change":0.025,"changeRate":0.034965,"amplitude":0.048951},"delay":0,"changeRate":-0.13845041571273647,"floatShares":17031100,"shares":19477400,"eps":-9.597297,"marketStatus":"休市中","change":-0.1149,"latestTime":"09-11 16:00:00 EDT","open":0.85,"high":0.899,"low":0.71,"amount":1516963.8481479,"amplitude":0.227738,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-9.597297,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.8299,"preHourTrading":{"tag":"盘前","latestPrice":0.8449,"preClose":0.8299,"latestTime":"09:04 EDT","volume":14030,"amount":11821.1168,"timestamp":1789131874108,"change":0.015,"changeRate":0.018074,"amplitude":0.047235},"postHourTrading":{"tag":"盘后","latestPrice":0.74,"preClose":0.715,"latestTime":"19:58 EDT","volume":9957,"amount":7416.9932,"timestamp":1789171129930,"change":0.025,"changeRate":0.034965,"amplitude":0.048951},"volumeRatio":3.3773163184306503},"requestUrl":"/m/hq/s/MBRX","defaultTab":"news","newsList":[{"id":"1149114268","title":"Moleculin Biotech发布2026年第二季度财报，并强调关键试验“奇迹”取得持续进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1149114268","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149114268?lang=zh_cn&edition=full","pubTime":"2026-08-14 20:31","pubTimestamp":1786710671,"startTime":"0","endTime":"0","summary":"Moleculin Biotech近日公布了其2026年第二季度的财务业绩，并特别强调了其核心临床试验——“奇迹”试验的持续推进态势。这一进展，无疑为公司的未来注入了新的动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166286945","title":"Moleculin Biotech“奇迹试验”A部分最终治疗预计2026年9月完成；揭盲结果将于2026年12月至2027年2月公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1166286945","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166286945?lang=zh_cn&edition=full","pubTime":"2026-07-31 20:11","pubTimestamp":1785499902,"startTime":"0","endTime":"0","summary":"Moleculin Biotech 的“奇迹试验”A部分迎来关键节点——最终治疗预计在2026年9月落地。紧随其后，揭盲结果将在2026年12月至2027年2月期间揭晓。此次试验的进展，为这家生物科技公司铺就了充满悬念与期待的下一征程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110441635","title":"Moleculin Biotech 奇迹试验：Venetoclax难治性R/R AML患者盲法CRC率达37%——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1110441635","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110441635?lang=zh_cn&edition=full","pubTime":"2026-07-31 20:09","pubTimestamp":1785499761,"startTime":"0","endTime":"0","summary":"Moleculin Biotech（股票代码：MBRX）在近期提交给美国证券交易委员会（SEC）的文件中披露了一项重大进展。其“奇迹试验”报告显示，针对曾接受Venetoclax治疗但失败后的复发/难治性急性髓系白血病（R/R AML）患者，该试验实现了37%的盲法完全缓解率（CRC）。这一数据令人瞩目，为那些传统疗法已失效的患者带来了新的希望。试验结果基于严格的盲法评估，排除了主观偏差，进一步强化了其治疗潜力的可信度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191791145","title":"Moleculin 公布2026年第一季度财务业绩并通报关键性Miracle试验临床进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1191791145","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191791145?lang=zh_cn&edition=full","pubTime":"2026-05-15 20:31","pubTimestamp":1778848276,"startTime":"0","endTime":"0","summary":"Moleculin Biotech, Inc. 已公布其2026年第一季度的财务业绩，并同步提供了关于其关键性Miracle试验的最新临床进展。\n公司报告了本季度的财务状况，同时详细阐述了其核心临床试验项目的当前状态与未来规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103229663","title":"Moleculin Biotech, Inc. (MBRX) 披露：MIRACLE试验A部分招募预计2026年第三季度完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1103229663","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103229663?lang=zh_cn&edition=full","pubTime":"2026-05-13 20:05","pubTimestamp":1778673914,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的文件，Moleculin Biotech, Inc. 宣布其MIRACLE临床试验的A部分患者招募工作正按计划推进，目标是在2026年第三季度完成。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131333484","title":"Moleculin公布2025财年全年业绩，确认关键性Miracle试验45名患者中期数据揭盲计划如期推进，预计2026年中完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1131333484","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131333484?lang=zh_cn&edition=full","pubTime":"2026-03-19 20:36","pubTimestamp":1773923818,"startTime":"0","endTime":"0","summary":"Moleculin Biotech, Inc. 近日公布了其2025财年全年的财务业绩。公司同时确认，其备受关注的关键性Miracle试验中，针对45名患者的中期数据揭盲计划正按既定时间表顺利推进，预计将在2026年中期完成这一重要节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518578222","title":"Moleculin Biotech, Inc.盘中异动 早盘急速下挫6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518578222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518578222?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613478,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Moleculin Biotech, Inc.股票出现异动，股价大幅下挫6.25%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1799.83%、382.57%、45.25%，振幅较大的相关个股有Xencor, Inc.、Y-Mabs Therapeutics, Inc.、Cadrenal Therapeutics, Inc.，振幅分别为99.13%、94.67%、9.44%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213118abf2fbbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213118abf2fbbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517165951","title":"Moleculin Biotech, Inc.盘中异动 早盘大幅下跌6.01%报1.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517165951?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:31","pubTimestamp":1741271476,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时31分，Moleculin Biotech, Inc.股票出现异动，股价大幅下挫6.01%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Plus Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Protagenic Therapeutics, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为928.69%、96.28%、46.90%，振幅较大的相关个股有Astria Therapeutics, Inc.、Plus Therapeutics, Inc.、Mbx Biosciences, Inc.，振幅分别为11.88%、11.14%、8.18%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223117963c4c75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223117963c4c75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517594667","title":"Moleculin Biotech, Inc.盘中异动 大幅拉升5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517594667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517594667?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:44","pubTimestamp":1741189495,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时44分，Moleculin Biotech, Inc.股票出现异动，股价大幅拉升5.56%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。其相关个股中，Chimerix, Inc.、Nutriband Inc C/Wts 、Oculis Holding Ag C/Wts 06/03/2028 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为876.21%、287.55%、270.12%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Nkgen Biotech, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为54.27%、42.66%、41.26%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305234456abe9c7d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305234456abe9c7d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516637373","title":"Moleculin Biotech, Inc.盘中异动 早盘急速跳水5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516637373?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:53","pubTimestamp":1741013620,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时53分，Moleculin Biotech, Inc.股票出现波动，股价快速下挫5.26%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为741.91%、115.36%、86.95%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为163.15%、70.53%、35.60%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225340abe63a95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225340abe63a95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514320033","title":"Moleculin Biotech, Inc.盘中异动 快速跳水6.30%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514320033?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:44","pubTimestamp":1740753858,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时44分，Moleculin Biotech, Inc.股票出现波动，股价快速跳水6.30%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为508.73%、326.85%、266.05%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Enveric Biosciences, Inc.、Salarius Pharmaceuticals, Inc.，振幅分别为31.14%、29.25%、22.28%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228224418a25804a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228224418a25804a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856909","title":"Moleculin Biotech, Inc.盘中异动 早盘股价大跌5.04%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514856909?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:34","pubTimestamp":1740580448,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时34分，Moleculin Biotech, Inc.股票出现波动，股价大幅下跌5.04%。截至发稿，该股报1.23美元/股，成交量65.8623万股，换手率15.85%，振幅3.10%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223408a254f731&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223408a254f731&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514162090","title":"Moleculin Biotech, Inc.股价飙升45.79% 市值涨296.86万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514162090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514162090?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:31","pubTimestamp":1740493893,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Moleculin Biotech, Inc.股票出现异动，股价快速拉升45.79%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Organovo Holdings, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为749.11%、542.73%、463.20%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Maze Therapeutics, Inc.，振幅分别为62.33%、19.20%、8.87%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223133abdc7dd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223133abdc7dd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513220987","title":"Moleculin Biotech, Inc.盘中异动 大幅跳水6.26%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513220987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513220987?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:37","pubTimestamp":1740407835,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时37分，Moleculin Biotech, Inc.股票出现异动，股价快速下挫6.26%。截至发稿，该股报1.20美元/股，成交量30.2007万股，换手率7.27%，振幅5.47%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242237169890f723&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242237169890f723&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513296657","title":"Moleculin Biotech, Inc.盘中异动 快速下跌6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513296657?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:44","pubTimestamp":1740149083,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时44分，Moleculin Biotech, Inc.股票出现异动，股价急速跳水6.43%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为79.25%、76.76%、32.89%，振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.，振幅分别为50.31%、46.92%、35.45%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224443988de16e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224443988de16e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2512838024","title":"Moleculin Biotech, Inc.盘中异动 早盘股价大跌11.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512838024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512838024?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:37","pubTimestamp":1739975829,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时37分，Moleculin Biotech, Inc.股票出现异动，股价快速下挫11.46%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为269.77%、206.87%、67.01%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Aditxt, Inc.、Azitra Inc，振幅分别为207.68%、19.64%、16.40%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223710988b327a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223710988b327a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165134","title":"Moleculin Biotech, Inc.盘中异动 急速下挫5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512165134?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889120,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Moleculin Biotech, Inc.股票出现异动，股价大幅下挫5.50%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为277.52%、92.38%、65.37%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Allogene Therapeutics, Inc.、Solid Biosciences Inc.，振幅分别为13.49%、12.01%、10.17%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223200abd3af35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223200abd3af35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MBRX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2511769622","title":"Moleculin Biotech, Inc.股价拉升74.75% 市值涨684.94万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511769622","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511769622?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:35","pubTimestamp":1739543712,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时35分，Moleculin Biotech, Inc.股票出现波动，股价大幅上涨74.75%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1116.01%、376.90%、348.40%，振幅较大的相关个股有Moleculin Biotech, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virpax Pharmaceuticals, Inc.，振幅分别为23.62%、20.20%、19.73%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422351296231c1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422351296231c1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2511760525","title":"Moleculin Biotech, Inc.盘中异动 急速拉升75.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511760525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511760525?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457092,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Moleculin Biotech, Inc.股票出现异动，股价大幅拉升75.69%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃，换手率分别为976.28%、786.68%、90.45%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Enliven Therapeutics, Inc.，振幅分别为21.43%、13.44%、7.85%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223132a244ab1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223132a244ab1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510638034","title":"Moleculin Biotech, Inc.股价重挫13.12% 市值跌26.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510638034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510638034?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:37","pubTimestamp":1739284641,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时37分，Moleculin Biotech, Inc.股票出现异动，股价快速下跌13.12%。Moleculin Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。其相关个股中，Dominari Holdings Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2146.29%、552.84%、205.40%，振幅较大的相关个股有In8Bio, Inc.、Dominari Holdings Inc.、Ocean Biomedical, Inc.，振幅分别为31.80%、25.49%、22.23%。Moleculin Biotech, Inc.公司简介：Moleculin Biotech Inc 是一家临床阶段制药公司，专注于开发用于治疗耐药性肿瘤和病毒的多种候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223721abcb077d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223721abcb077d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MBRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.moleculin.com","stockEarnings":[{"period":"1week","weight":0.0072},{"period":"1month","weight":0.3692},{"period":"3month","weight":-0.7292},{"period":"6month","weight":-0.6495},{"period":"1year","weight":-0.9239},{"period":"ytd","weight":-0.784}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moleculin Biotech, Inc.是一家于2015年7月在特拉华州成立的临床药物研制公司，着眼于开发抗癌药物的研发，主要与德克萨斯州大学的M.D. Anderson癌症中心合作。该公司的主要研制药品是脂质的安那霉素，用于治疗复发性或急性白血病。除此之外还有两种正在开发的其他药物，一是WP1066药物，主要控制参与癌症的关键转录调控因子；二是WP1122药物，主要通过分子靶来影响癌症细胞的代谢过程。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.015822},{"month":2,"riseRate":0.2,"avgChangeRate":-0.114621},{"month":3,"riseRate":0.2,"avgChangeRate":-0.117346},{"month":4,"riseRate":0.5,"avgChangeRate":0.083166},{"month":5,"riseRate":0.2,"avgChangeRate":-0.058144},{"month":6,"riseRate":0.2,"avgChangeRate":0.034332},{"month":7,"riseRate":0.545455,"avgChangeRate":0.080887},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.060419},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.024011},{"month":10,"riseRate":0.1,"avgChangeRate":-0.140808},{"month":11,"riseRate":0.5,"avgChangeRate":0.009369},{"month":12,"riseRate":0.3,"avgChangeRate":-0.109934}],"exchange":"NASDAQ","name":"Moleculin Biotech, Inc.","nameEN":"Moleculin Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Moleculin Biotech, Inc.(MBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moleculin Biotech, Inc.(MBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moleculin Biotech, Inc.,MBRX,Moleculin Biotech, Inc.股票,Moleculin Biotech, Inc.股票老虎,Moleculin Biotech, Inc.股票老虎国际,Moleculin Biotech, Inc.行情,Moleculin Biotech, Inc.股票行情,Moleculin Biotech, Inc.股价,Moleculin Biotech, Inc.股市,Moleculin Biotech, Inc.股票价格,Moleculin Biotech, Inc.股票交易,Moleculin Biotech, Inc.股票购买,Moleculin Biotech, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moleculin Biotech, Inc.(MBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moleculin Biotech, Inc.(MBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}